BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9512255)

  • 1. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A; Alvarez F; Brache V; Cochón L
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E; Vekemans M; Galant C; Rigot V; Lemoine P; Dubois D; Picquet C; Henriet P; Twagirayezu P; Sufi S; Eeckhout Y; Courtoy PJ
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norplant users with irregular bleeding. Ultrasonographic assessment and evaluation of serum concentrations of estradiol and progesterone.
    Kaewrudee S; Taneepanichskul S
    J Reprod Med; 2000 Dec; 45(12):983-6. PubMed ID: 11153258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M; Fraser I; Dwarte D; Graham S
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial vasculature in Norplant users.
    Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding.
    Rogers PA; Lederman F; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():152-61. PubMed ID: 11041231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
    Hickey M; Fraser IS
    Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
    Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement of endometrial perfusion in norplant users: a pilot study.
    Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
    Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
    Hickey M; Dwarte D; Fraser IS
    Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
    Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
    Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial biopsy collection from women receiving Norplant.
    Hadisaputra W; Affandi B; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():31-4. PubMed ID: 8982743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM; Rogers PA; Affandi B
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.